What the research shows To explore whether GLP-1 medications are associated with increased risk of gastrointestinal conditions, a recent study compared over 200,000 individuals taking GLP-1 medications with a group taking other type 2 diabetes medications (1)
Unlike many people drawn to semaglutide, McCullar didn't have "food chatter" or binge-eating tendencies, but even after tracking her macros and working with a trainer, she was still struggling
Next, detailed health history focusing on pancreatitis diagnosis, gastroparesis symptoms, and medical treatment received is collected
Our policy on illegal activities and regulated goods prohibits the promotion of nasal tanning sprays, and we have removed the videos that you have shared with us. So next time youre scrolling through social media, if you see something that seems too good to be true, it most likely is, let alone a dermatologists nightmare